Literature DB >> 6832807

Differential susceptibility of chlamydiae to exogenous fibroblast interferon.

G I Byrne, C D Rothermel.   

Abstract

Mouse fibroblasts (L cells) were incubated for 5 h with 1,000 U of murine fibroblast interferon (MuIFN alpha+ beta) per ml and then were infected with either Chlamydia trachomatis (LGV 440), C. psittaci (6BC), or C. psittaci (Cal 10). Intracellular development of C. trachomatis was reduced 90% in interferon-treated cells 24 h after infection when compared with controls, whereas C. psittaci growth was not affected in interferon-treated cells.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6832807      PMCID： PMC348050          DOI： 10.1128/iai.39.2.1004-1005.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  10 in total

1.  Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group).

Authors:  S P Dhir; S Hakomori; G E Kenny; J T Grayston
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

2.  Induction of interferon by the Bour strain of trachoma in HeLa 229 cells.

Authors:  H M Jenkin; Y K Lu
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

3.  Production of high-titered interferon in cultures of human diploid cells.

Authors:  E A Havell; J Vilcek
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

4.  Lack of deoxyribonucleic acid homology between species of the genus Chlamydia.

Authors:  D T Kingsbury; E Weiss
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

5.  Competition between Chlamydia psittaci and L cells for host isoleucine pools: a limiting factor in chlamydial multiplication.

Authors:  T P Hatch
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

Review 6.  Chlamydiae.

Authors:  J Schachter; H D Caldwell
Journal:  Annu Rev Microbiol       Date:  1980       Impact factor: 15.500

7.  Inhibition of TRIC agents by virus-induced interferon.

Authors:  L Hanna; T C Merigan; E Jawetz
Journal:  Proc Soc Exp Biol Med       Date:  1966-06

8.  Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. II. A trachoma-LGV-specific antigen.

Authors:  H D Caldwell; C C Kuo; G E Kenny
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

9.  Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells.

Authors:  G I Byrne; J W Moulder
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Effect of Interferon and Interferon Inducers on Infections with a Nonviral Intracellular Microorganism, Chlamydia trachomatis.

Authors:  J Kazar; J D Gillmore; F B Gordon
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441
  10 in total
  6 in total

1.  Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon.

Authors:  R P Morrison
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 2.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

3.  Chlamydia muridarum infection elicits a beta interferon response in murine oviduct epithelial cells dependent on interferon regulatory factor 3 and TRIF.

Authors:  Wilbert A Derbigny; Soon-Cheol Hong; Micah S Kerr; M'hamed Temkit; Raymond M Johnson
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

4.  Selective infection of astrocytes by Chlamydia trachomatis in primary mixed neuron-glial cell cultures.

Authors:  D Levitt; R Danen; P Levitt
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

5.  Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin.

Authors:  G I Byrne; D A Krueger
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

6.  The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanism.

Authors:  Xianbao He; Robert Berland; Samrawit Mekasha; Thomas G Christensen; Joseph Alroy; Igor Kramnik; Robin R Ingalls
Journal:  PLoS Pathog       Date:  2013-08-29       Impact factor: 6.823
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.